This inventor holds 2 USPTO granted patents and 8 published patent applications. Top assignees: Beth Israel Deaconess Medical Center, Inc., Janssen Pharmaceuticals, Inc., Other. Active years: 2014-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 539 
1 out of 161 
1 out of 834,570 Years Active: 2014-2020
Title: Gaston Rafael Picchio: Innovator in Viral Therapeutics
Introduction
Gaston Rafael Picchio is a notable inventor based in Flemington, NJ (US), recognized for his contributions to the field of viral therapeutics. With a total of two patents to his name, Picchio has made significant strides in developing methods for combating viral infections.
Latest Patents
His latest patents include a method for providing safe administration of adenoviral vectors encoding a Zika virus antigen. This invention outlines methods for generating an immune response against the Zika virus in human subjects. The methods involve administering a pharmaceutical composition that includes adenoviral vectors encoding a Zika virus antigen along with a pharmaceutically acceptable carrier. Another significant patent focuses on a therapeutic regimen comprising PEG-interferon, ribavirin, and VX-950 for treating hepatitis. This invention relates to antiviral therapies and compositions aimed at treating or preventing Hepatitis C infections in patients, along with related kits and pharmaceutical packs.
Career Highlights
Throughout his career, Picchio has worked with prominent organizations such as Janssen Pharmaceuticals, Inc. and Beth Israel Deaconess Medical Center, Inc. His work in these institutions has contributed to advancements in medical research and therapeutic development.
Collaborations
Picchio has collaborated with esteemed colleagues, including Dan H Barouch and Macaya Julie Douoguih, further enhancing the impact of his research and innovations.
Conclusion
Gaston Rafael Picchio's work in the field of viral therapeutics exemplifies the importance of innovation in addressing public health challenges. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile